DOI QR코드

DOI QR Code

호흡기내과 의사를 위한 Respiratory Review of 2009: 비결핵 항산균

Respiratory Review of 2009: Nontuberculous Mycobacterium

  • 박재석 (단국대학교 의과대학 내과학교실)
  • Park, Jae Seuk (Department of Internal Medicine, Dankook University College of Medicine)
  • 투고 : 2009.06.08
  • 심사 : 2009.06.10
  • 발행 : 2009.11.30

초록

As the prevalence of tuberculosis declines, the proportion of nontuberculous mycobacterial (NTM) lung disease is increasing in Korea. The combined use of liquid and solid media increases the sensitivity of mycobacterial culture and shortens culture time. Because NTMs are ubiquitous in the environment, NTM lung disease requires strict diagnostic criteria to prevent over-diagnosis of NTM lung disease. Mycobacterium avium complex is the most common pathogen of NTM lung disease in Korea and present in two forms: upper lobe cavitary and nodular bronchiectatic form. Decision of treatment of NTM lung disease depends on the infecting species and overall condition of the patient. Because medical therapy requires the use of multiple drugs over 18 to 24 months, surgery for localized disease may be useful for those species refractory to medical therapy.

키워드

참고문헌

  1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A,Daley C, Gordin F, et al. An official ATS/IDSA statement:diagnosis, treatment, and prevention of nontuberculousmycobacterial diseases. Am J Respir CritCare Med 2007;175:368-416
  2. Lee JY, Choi HJ, Lee H, Joung EY, Huh JW, Oh YM,et al. Recovery rate and characteristics of nontuberculousmycobacterial isolates in a university hospital inKorea. Tuberc Respir Dis 2005;58:385-91
  3. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, ParkSN, et al. Spread of nontuberculous mycobacteria from1993 to 2006 in Koreans. J Clin Lab Anal 2008;22:416-20
  4. Bae E, Im JH, Kim SW, Yoon NS, Sung H, Kim MN,et al. Evaluation of combination of BACTEC Mycobacteriagrowth indicator tube 960 system and Ogawa mediafor mycobacterial culture. Korean J Lab Med 2008;28:299-306 https://doi.org/10.3343/kjlm.2008.28.4.299
  5. Diagnosis and treatment of disease caused by nontuberculousmycobacteria. This official statement of theAmerican Thoracic Society was approved by the Boardof Directors, March 1997. Medical Section of the AmericanLung Association. Am J Respir Crit Care Med 1997;156:S1-25 https://doi.org/10.1164/ajrccm.156.2.atsstatement
  6. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK,et al. Clinical significance of nontuberculous mycobacteriaisolated from respiratory specimens in Korea. Chest 2006;129:341-8 https://doi.org/10.1378/chest.129.2.341
  7. Subcommittee of the Joint Tuberculosis Committee ofthe British Thoracic Society. Management of opportunistmycobacterial infections: Joint Tuberculosis CommitteeGuidelines 1999. Thorax 2000;55:210-8 https://doi.org/10.1136/thorax.55.3.210
  8. Koh WJ, Kwon OJ. Diagnosis and treatment of nontuberculousmycobacterial lung disease. Korean J Med 2008;74:120-31
  9. Koh WJ, Kim YH, Kwon OJ, Choi YS, Kim K, ShimYM, et al. Surgical treatment of pulmonary diseasesdue to nontuberculous mycobacteria. J Korean Med Sci 2008;23:397-401 https://doi.org/10.3346/jkms.2008.23.3.397

피인용 문헌

  1. 심장이식 환자에서 발생한 비결핵항산균 폐질환 2예 vol.69, pp.3, 2009, https://doi.org/10.4046/trd.2010.69.3.201
  2. Performance of a real-time PCR assay for the rapid identification of Mycobacterium species vol.53, pp.1, 2009, https://doi.org/10.1007/s12275-015-4495-8
  3. 마이코박테리아 검출을 위하여 MGIT 양성 신호를 보인 세균에 오염된 검체 재처리 과정의 효율성 평가 vol.51, pp.2, 2009, https://doi.org/10.15324/kjcls.2019.51.2.171